Autoimmune Blistering Diseases in the Elderly: Clinical Presentations and Management

被引：6

作者：

Kim, Minhee ^{[1
,2
]}

Borradori, Luca ^{[3
]}

Murrell, Dedee F. ^{[1
,2
]}

机构：

[1] St George Hosp, Dept Dermatol, Gray St, Sydney, NSW 2217, Australia

[2] Univ New South Wales, Sydney, NSW, Australia

[3] Univ Hosp Bern, Dept Dermatol, Inselspital, Bern, Switzerland

来源：

DRUGS & AGING | 2016年 / 33卷 / 10期

关键词：

EPIDERMOLYSIS-BULLOSA-ACQUISITA; INTRAVENOUS IMMUNOGLOBULIN; TOPICAL CORTICOSTEROIDS; DIFFERENTIAL-DIAGNOSIS; PEMPHIGUS; SKIN; DISORDERS; RITUXIMAB; THERAPY; RISK;

D O I：

10.1007/s40266-016-0402-1

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

Elderly patients are more susceptible to the development of autoimmune blistering disorders such as bullous pemphigoid, mucous membrane pemphigoid, epidermolysis bullosa acquisita, and paraneoplastic pemphigus. This article focuses on the clinical aspects of the aforementioned autoimmune blistering diseases and highlights the important factors involved in treating elderly patients. It is essential for clinicians to offer individualized treatment plans for these patients to optimize outcomes, as elderly patients often have multiple co-morbidities, polypharmacy, and suboptimal socioeconomic status that can adversely influence adequate compliance.

引用

页码：711 / 723

页数：13

共 107 条

[1] Treatment of epidermolysis bullosa acquisita with intravenous immunoglobulin in patients non-responsive to conventional therapy: clinical outcome and post-treatment long-term follow-up [J].

Ahmed, A. R. ;

Guercan, H. M. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2012, 26 (09) :1074-1083

[2] A prospective study of upper aerodigestive tract manifestations of mucous membrane pemphigoid [J].

Alexandre, Marina ;

Brette, Marie-Dominique ;

Pascal, Francis ;

Tsianakas, Paul ;

Fraitag, Sylvie ;

Doan, Serge ;

Caux, Frederic ;

Dupuy, Alain ;

Heller, Michel ;

Lievre, Nicole ;

Lepage, Virginia ;

Dubertret, Louis ;

Laroche, Liliane ;

Prost-Squarcioni, Catherine .

MEDICINE, 2006, 85 (04) :239-252

[3] Intravenous immune globulin and thromboembolic adverse events: A systematic review and meta-analysis of RCTs [J].

Ammann, Eric M. ;

Haskins, Cole B. ;

Fillman, Kelsey M. ;

Ritter, Rebecca L. ;

Gu, Xiaomei ;

Winiecki, Scott K. ;

Carnahan, Ryan M. ;

Torner, James C. ;

Fireman, Bruce H. ;

Jones, Michael P. ;

Chrischilles, Elizabeth A. .

AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (06) :594-605

[4]

Anhalt G J, 1997, Adv Dermatol, V12, P77

[5] A Case Report of Bullous Pemphigoid Induced by Dipeptidyl Peptidase-4 Inhibitors [J].

Aouidad, Iman ;

Fite, Charlotte ;

Marinho, Eduardo ;

Deschamps, Lydia ;

Crickx, Beatrice ;

Descamps, Vincent .

JAMA DERMATOLOGY, 2013, 149 (02) :243-245

[6]

Aprey CJ, 1991, J AM ACAD DERMATOL, V24, P706

[7] Bullous pemphigoid associated with dipeptidyl peptidase IV inhibitors. A case report and review of literature [J].

Attaway, Amy ;

Mersfelder, Tracey L. ;

Vaishnav, Sakshi ;

Baker, Joanne K. .

JOURNAL OF DERMATOLOGICAL CASE REPORTS, 2014, 8 (01) :24-28

[8]

Baican A, 2010, INT J DERMATOL, V49, P768, DOI 10.1111/j.1365-4632.2009.04345.x

[9]

BERBIS P, 1989, ANN DERMATOL VENER, V116, P301

[10] INCIDENCE AND DISTRIBUTION OF SUBEPIDERMAL AUTOIMMUNE BULLOUS SKIN DISEASES IN 3 FRENCH REGIONS [J].

BERNARD, P ;

VAILLANT, L ;

LABEILLE, B ;

BEDANE, C ;

ARBEILLE, B ;

DENOEUX, JP ;

LORETTE, G ;

BONNETBLANC, JM ;

PROST, C .

ARCHIVES OF DERMATOLOGY, 1995, 131 (01) :48-52

← 1 2 3 4 5 6 7 8 9 10 →